SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Judy who wrote (4271)7/12/1998 9:02:00 PM
From: Nancy  Read Replies (1) | Respond to of 9523
 
Hi there, thanks for the information. I believe IMNX has filed for fast track approval for Enbrel.
Need to verify that and if otherwise will post.

PFE's Celebral has not filed for anything yet, schedule is in 1999. The thing confuses me is PFE said Celebral will be effective in BOTH RA and OsteoA treatment, and would be first of its kind.

Looks like Enbrel has a headstart here. Doesn't matter to me, I have both, just want to know more about both.




To: Judy who wrote (4271)7/12/1998 9:15:00 PM
From: Solid  Read Replies (2) | Respond to of 9523
 
Thanks to all regulars, many I wager with years of experience both investing and in this industry- I have benefited and profited from your 'steady' insights. BigK, you are a rock!

A touch off topic but this may help many for a long time to come as an easy bookmark...


Came across a great simple to use site loaded with medical info. including 10yrs. of indexed medical studies/articles in consumer friendly format. Any with health questions or interested about the latest research, or past stories missed may enjoy a hit here once and a while. Title, 48hours, is because it highlights the past 48 news hours of medical story releases. I heard it mentioned today on CBS news radio, NYC.

FYI-

48hours.net

I find myself waiting for Mr. Peobody's Report, like my black Lab awaits my return to get his treat and play time!

Go PFE'rrr!!!